These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 8109921
21. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity. Fournier B, Hooper DC. Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271 [Abstract] [Full Text] [Related]
22. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. Yasuda M, Fukuda H, Yokoi S, Ishihara S, Kawada Y, Deguchi T. J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166 [Abstract] [Full Text] [Related]
23. In vitro plasmid-encoded resistance to quinolones. Gómez-Gómez JM, Blázquez J, Espinosa De Los Monteros LE, Baquero MR, Baquero F, Martínez JL. FEMS Microbiol Lett; 1997 Sep 15; 154(2):271-6. PubMed ID: 9311124 [Abstract] [Full Text] [Related]
24. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A, Blanche F. Mol Microbiol; 1994 Aug 15; 13(4):641-53. PubMed ID: 7997176 [Abstract] [Full Text] [Related]
25. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance. Yonezawa M, Takahata M, Banzawa N, Matsubara N, Watanabe Y, Narita H. Microbiol Immunol; 1995 Aug 15; 39(7):517-20. PubMed ID: 8569537 [Abstract] [Full Text] [Related]
26. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro. Tanaka M, Sakuma S, Takahashi K, Nagahuzi T, Saika T, Kobayashi I, Kumazawa J. Sex Transm Infect; 1998 Feb 15; 74(1):59-62. PubMed ID: 9634306 [Abstract] [Full Text] [Related]
27. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Ng EY, Trucksis M, Hooper DC. Antimicrob Agents Chemother; 1996 Aug 15; 40(8):1881-8. PubMed ID: 8843298 [Abstract] [Full Text] [Related]
28. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Antimicrob Agents Chemother; 1996 Aug 15; 40(8):1768-74. PubMed ID: 8843279 [Abstract] [Full Text] [Related]
29. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa. Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H. Antimicrob Agents Chemother; 1995 Sep 15; 39(9):1970-2. PubMed ID: 8540700 [Abstract] [Full Text] [Related]
30. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J. J Antimicrob Chemother; 1999 Dec 15; 44(6):743-8. PubMed ID: 10590274 [Abstract] [Full Text] [Related]
31. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations. Herrera G, Aleixandra V, Urios A, Blanco M. FEMS Microbiol Lett; 1993 Jan 15; 106(2):187-91. PubMed ID: 8384139 [Abstract] [Full Text] [Related]
33. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, Ishihara S, Kawada Y. Antimicrob Agents Chemother; 1998 Dec 15; 42(12):3293-5. PubMed ID: 9835531 [Abstract] [Full Text] [Related]
34. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Mouneimné H, Robert J, Jarlier V, Cambau E. Antimicrob Agents Chemother; 1999 Jan 15; 43(1):62-6. PubMed ID: 9869566 [Abstract] [Full Text] [Related]
35. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections. Ozeki S, Deguchi T, Yasuda M, Nakano M, Kawamura T, Nishino Y, Kawada Y. J Clin Microbiol; 1997 Sep 15; 35(9):2315-9. PubMed ID: 9276409 [Abstract] [Full Text] [Related]
36. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Cullen ME, Wyke AW, Kuroda R, Fisher LM. Antimicrob Agents Chemother; 1989 Jun 15; 33(6):886-94. PubMed ID: 2548439 [Abstract] [Full Text] [Related]
38. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase. Onodera Y, Sato K. Antimicrob Agents Chemother; 1999 Oct 15; 43(10):2423-9. PubMed ID: 10508019 [Abstract] [Full Text] [Related]
39. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. Truong QC, Nguyen Van JC, Shlaes D, Gutmann L, Moreau NJ. Antimicrob Agents Chemother; 1997 Jan 15; 41(1):85-90. PubMed ID: 8980760 [Abstract] [Full Text] [Related]
40. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA. Masecar BL, Robillard NJ. Antimicrob Agents Chemother; 1991 May 15; 35(5):898-902. PubMed ID: 1649573 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]